ATF2 and neoplasm: EBNA1 activating AP‐1 transcription factor pathway by binding to ATF2 and elevated expression of AP‐1 targeting VEGF; SARS and ROCK1/2 are unique regulators in angiogenesis and angiosarcoma tumour progression.